| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6167586 | Urology | 2013 | 6 Pages |
Abstract
Chemotherapy plus ADT for BR resulted in durable (>5 years) complete responses (<0.1 ng/mL) in 7 men (11%). Twenty-four percent of men have not re-initiated ADT 5 years from completion of protocol therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Mari Nakabayashi, Wanling Xie, Geoffrey Buckle, Glenn Bubley, Marc S. Ernstoff, William Walsh, Daniel E. Morganstern, Philip W. Kantoff, Mary-Ellen Taplin,